https://clinicaltrials.gov/ct2/show/NCT03611751?type=Intr&cond=Psoriasis&lupd_s=03%2F20%2F2019&lupd_d=14
Condition : Psoriasis
Interventions : Drug: BMS-986165; Other: Placebo; Drug: Apremilast
Sponsor : Bristol-Myers Squibb
Recruiting
An Investigational Study to Evaluate Experimental Medication BMS-986165 Compared to Placebo and a Currently Available Treatment in Participants With Moderate-to-Severe Plaque Psoriasis
NCT03611751
Thu, 02 Aug 2018 12:00:00 EDT
Last Update Posted: 04/03/19 07:43AM